AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015, 22.24

AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015, 22.24

AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015, 22.24 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests, for the first time, that MiRNA-152, by suppressing the expression of its target gene, it may increase pulmonary arterial hypertension. Thus, pharmacological formulations encompassing “MiRNA-152 inhibitors“ may be used to treat pulmonary arterial hypertension (PAH).

Amount: $ 300*

Undisclosed information: How MiRNA-152 increases pulmonary arterial hypertension

To cite: Boominathan, AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases  pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015,  22.24,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Share
Start Typing